Form 4 · Filed Jun 29, 2026, 08:02 PM UTC
PHIO/Phio Pharmaceuticals Corp.
Bitterman Robert J — Chairman, Pres. & CEO
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
1 row| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 26, 2026 | P | buy | 10,000 | $1 | $9,900 | 421,421 |
Source: SEC EDGAR raw filing ↗ · Accession 0001683168-26-005164